title: Prevalence of cervical human papillomavirus in women undergoing in vitro fertilization and association with outcome.
abstract: Human papillomavirus (HPV) was detected in 17 (16.0%) of 106 patients undergoing treatment for IVF. Human papillomavirus-positive women had a decreased pregnancy rate (4 of 17, 23.5%) as compared with HPV-negative women (51 of 89, 57.0%; P<.02).
authors.affiliation: The Center for Reproductive Medicine and Infertility, The New York Presbyterian Hospital, Weill Medical College of Cornell University, New York, New York 10021, USA. sdspando@med.cornell.edu
authors.forename: Steven D
authors.initials: SD
authors.lastname: Spandorfer
authors.forename: Anne Marie
authors.initials: AM
authors.lastname: Bongiovanni
authors.forename: Sozos
authors.initials: S
authors.lastname: Fasioulotis
authors.forename: Zev
authors.initials: Z
authors.lastname: Rosenwaks
authors.forename: William J
authors.initials: WJ
authors.lastname: Ledger
authors.forename: Steven S
authors.initials: SS
authors.lastname: Witkin
mesh_terms: D000328:Adult; D005260:Female; D005307:Fertilization in Vitro / Q000706:statistics & numerical data*; D006801:Humans; D007247:Infertility, Female / Q000453:epidemiology* / Q000628:therapy* / Q000821:virology; D027383:Papillomaviridae / Q000302:isolation & purification*; D030361:Papillomavirus Infections / Q000453:epidemiology* / Q000821:virology; D011247:Pregnancy; D011256:Pregnancy Outcome / Q000453:epidemiology*; D015995:Prevalence; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000821:virology